Attitudes and knowledge about weight management among primary care physicians in Israel: a cross-sectional study.

Keren Or Unger Freinkel, Ilan Yehoshua, Bar Cohen, Roni Peleg, Limor Adler
Author Information
  1. Keren Or Unger Freinkel: Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  2. Ilan Yehoshua: Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  3. Bar Cohen: Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  4. Roni Peleg: Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  5. Limor Adler: Department of Family Medicine, Maccabi Healthcare Services, Tel Aviv University, Hamered 27 St., Tel Aviv, Israel. limchuk@gmail.com.

Abstract

BACKGROUND: The prevalence of obesity has been increasing worldwide and is associated with increased risk of morbidity and mortality. Weight management can reduce the risk of complications and improve the quality of life of patients with obesity. This study explored primary care physicians' (PCPs') attitudes and knowledge about weight management.
METHODS: An anonymous questionnaire was distributed to 400 PCPs between 2020 and 2021. The survey included questions on treatment approaches (pharmaceutical and surgical) and items regarding the respondents' demographic characteristics. We compared PCPs with low or high proactivity toward weight management. We explored attitudes and knowledge with the chi-square test for categorical variables or the Mann-Whitney test for continuous variables.
RESULTS: A total of 145 PCPs answered our survey (a response rate of 36.25%). More than half (53.8%) of the respondents showed low proactivity toward weight management in their practice. Proactive respondents were more likely to believe that pharmaceutical treatment effectively reduces weight and offered medical and surgical treatment options more frequently to their patients. Lack of knowledge was the most predominant reason for PCPs avoiding offering treatment to their patients, especially in less proactive PCPs (33.3% vs. 5.3%, p-value���<���0.001). When comparing different pharmaceutical options, 46.6% of PCPs report they tend to prescribe liraglutide to their patients compared with only 11% who prescribe orlistat and 10.3% who prescribe phentermine (p-value���<���0.001).
CONCLUSIONS: Many PCPs still do not actively provide obesity treatment despite improved awareness and therapeutic options. PCPs' proactivity and attitudes are vital to this effort.

Keywords

References

  1. Fam Pract. 2014 Feb;31(1):38-43 [PMID: 24132593]
  2. J Med Internet Res. 2021 Aug 9;23(8):e24017 [PMID: 34383661]
  3. Surg Obes Relat Dis. 2018 Mar;14(3):376-380 [PMID: 29254687]
  4. J Gen Intern Med. 2022 Aug;37(10):2548-2552 [PMID: 35474504]
  5. N Engl J Med. 2022 Jul 21;387(3):205-216 [PMID: 35658024]
  6. Curr Obes Rep. 2016 Sep;5(3):327-32 [PMID: 27342445]
  7. BMC Prim Care. 2022 Aug 16;23(1):208 [PMID: 35971075]
  8. J Prim Care Community Health. 2019 Jan-Dec;10:2150132719870879 [PMID: 31496342]
  9. Int J Obes Relat Metab Disord. 2002 Oct;26(10):1393-7 [PMID: 12355337]
  10. Patient Educ Couns. 2017 May;100(5):897-908 [PMID: 28089308]
  11. JAMA. 2015 Jan 6;313(1):62-70 [PMID: 25562267]
  12. Obesity (Silver Spring). 2022 Apr;30(4):802-840 [PMID: 35333446]
  13. BMC Fam Pract. 2013 Oct 19;14:156 [PMID: 24138355]
  14. Curr Obes Rep. 2017 Jun;6(2):187-194 [PMID: 28455679]
  15. Obes Res Clin Pract. 2017 May - Jun;11(3):352-359 [PMID: 27569863]
  16. Lancet Diabetes Endocrinol. 2018 Mar;6(3):237-248 [PMID: 28919062]
  17. Nat Rev Endocrinol. 2018 Jan;14(1):12-24 [PMID: 29027993]
  18. Obes Res Clin Pract. 2015 Nov-Dec;9(6):573-83 [PMID: 25791741]
  19. Clin Cornerstone. 1999;2(3):17-31 [PMID: 10696282]
  20. Lancet. 2012 Jun 16;379(9833):2243-51 [PMID: 22683134]
  21. N Engl J Med. 2017 Jul 6;377(1):13-27 [PMID: 28604169]
  22. Nutrients. 2023 Jun 27;15(13): [PMID: 37447247]
  23. Obes Surg. 2023 Jan;33(1):3-14 [PMID: 36336720]
  24. Obes Rev. 2015 Apr;16(4):319-26 [PMID: 25752756]
  25. Ann N Y Acad Sci. 2013 Apr;1281:191-206 [PMID: 23323827]
  26. Natl Health Stat Report. 2021 Jun 14;(158): [PMID: 39380201]
  27. Obes Sci Pract. 2021 May 21;7(6):659-668 [PMID: 34877005]
  28. BMJ. 2014 Aug 27;349:g3961 [PMID: 25164369]
  29. N Engl J Med. 2023 Aug 10;389(6):514-526 [PMID: 37366315]
  30. Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921 [PMID: 27595918]

MeSH Term

Humans
Cross-Sectional Studies
Physicians, Primary Care
Israel
Quality of Life
Obesity
Pharmaceutical Preparations

Chemicals

Pharmaceutical Preparations

Word Cloud

Created with Highcharts 10.0.0PCPsmanagementtreatmentweightpatientsknowledgeobesitycareattitudespharmaceuticalproactivityoptions3%prescriberiskWeightstudyexploredprimaryPCPs'surveysurgicalcomparedlowtowardtestvariablesrespondentsp-value���<���0001AttitudesphysiciansBACKGROUND:prevalenceincreasingworldwideassociatedincreasedmorbiditymortalitycanreducecomplicationsimprovequalitylifephysicians'METHODS:anonymousquestionnairedistributed40020202021includedquestionsapproachesitemsregardingrespondents'demographiccharacteristicshighchi-squarecategoricalMann-WhitneycontinuousRESULTS:total145answeredresponserate3625%half538%showedpracticeProactivelikelybelieveeffectivelyreducesofferedmedicalfrequentlyLackpredominantreasonavoidingofferingespeciallylessproactive33vs5comparingdifferent466%reporttendliraglutide11%orlistat10phentermineCONCLUSIONS:ManystillactivelyprovidedespiteimprovedawarenesstherapeuticvitaleffortamongIsrael:cross-sectionalKnowledgeObesityPharmaceuticalPrimary

Similar Articles

Cited By

No available data.